Shareholder alert: weiss law investigates spectrum pharmaceuticals, inc.

New york , april 27, 2023 /prnewswire/ -- weiss law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of spectrum pharmaceuticals, inc. ("spectrum pharmaceuticals" or the "company") (nasdaq: sppi), in connection with its acquisition by assertio holdings, inc. (nasdaq: asrt) ("assertio"). under the merger agreement, the company's shareholders will receive 0.1783 shares of assertio common stock for each of their shares, representing implied per-share consideration of $0.89 based upon assertio's april 26, 2023 closing price of $5.00.
ASRT Ratings Summary
ASRT Quant Ranking